Cheryl Wellington

is Professor, Pathology and Laboratory Medicine, University of British Columbia, and has built an internationally recognized research program that focuses on neurological disease, with a particular emphasis on Alzheimer’s Disease and Traumatic Brain Injury. Her formal affiliations with the Djavad Mowafaghian Centre for Brain Health, Vancouver Coastal Health Research Institute, the UBC School of Biomedical Engineering and the International Collaboration on Repair Discoveries attest to the interdisciplinary nature of her research program and training environment. She holds a variety of national and international leadership positions, including executive positions in the Canadian Traumatic Brain Injury Research Consortium, the Canadian Concussion Network, and the International Initiative on Traumatic Brain Injury Research. Dr. Wellington has also served in leadership roles in the Cure Alzheimer Fund Research Leaders Group and the Canadian Consortium for Neurodegeneration in Aging. She is currently leading major national initiatives in neurology fluid biomarker innovation, spanning multiple neurodegenerative, neuroinflammatory and neurotrauma indications from community-based studies to neurocritical care.

Dr. Wellington obtained her PhD at the University of British Columbia (UBC) and performed postdoctoral fellowships at Harvard Medical School, the University of Calgary, and UBC.